Impact of immune checkpoint inhibitors (ICIs) therapy on interferon-γ release assay (IGRA) and diagnostic value in non-small cell lung cancer (NSCLC) patients.

BMC Pulm Med · 2024 · PMC11010406 · PMID 38609918

Europe PMC DOI

hedged sentence

0.1860

closest p · 3.7× alpha

0.1860

boldest claim

The sentences

did not reach statistical significanceP = 0.186not close (p > 0.1)

However, the difference between the two groups did not reach statistical significance ( P = 0.186, Table 2 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.